Hao Xu

3.5k total citations · 1 hit paper
109 papers, 2.6k citations indexed

About

Hao Xu is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Hao Xu has authored 109 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 30 papers in Hepatology and 23 papers in Surgery. Recurrent topics in Hao Xu's work include Liver Disease and Transplantation (25 papers), Organ Transplantation Techniques and Outcomes (15 papers) and Liver Disease Diagnosis and Treatment (15 papers). Hao Xu is often cited by papers focused on Liver Disease and Transplantation (25 papers), Organ Transplantation Techniques and Outcomes (15 papers) and Liver Disease Diagnosis and Treatment (15 papers). Hao Xu collaborates with scholars based in China, United States and Japan. Hao Xu's co-authors include Raoul Kopelman, Martin A. Philbert, De Gao, Fei Yan, Eric Monson, Lin Wang, Weilin Wang, Qianhui Xu, Lu Wang and Steven H. Liang and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hao Xu

103 papers receiving 2.6k citations

Hit Papers

Marriage of black phosphorus and Cu2+ as effective photot... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy
    2020 303 citations Kuan Hu, Hao Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Xu China 27 842 731 547 421 413 109 2.6k
Jinlan Jiang China 30 973 1.2× 1.0k 1.4× 721 1.3× 551 1.3× 172 0.4× 98 2.8k
Markus Heine Germany 22 530 0.6× 831 1.1× 487 0.9× 567 1.3× 138 0.3× 53 2.8k
Dawidson Assis Gomes Brazil 36 433 0.5× 1.7k 2.4× 207 0.4× 420 1.0× 372 0.9× 134 3.8k
Massoud Vosough Iran 34 957 1.1× 1.3k 1.8× 95 0.2× 333 0.8× 616 1.5× 174 3.5k
Katsunori Sasaki Japan 40 544 0.6× 2.5k 3.5× 156 0.3× 527 1.3× 163 0.4× 163 5.1k
Nan Zhao China 31 730 0.9× 1.0k 1.4× 819 1.5× 912 2.2× 51 0.1× 108 3.3k
Noriko Sato Japan 39 555 0.7× 1.2k 1.7× 553 1.0× 379 0.9× 65 0.2× 187 5.2k
Nathalie Luciani France 31 1.6k 1.9× 827 1.1× 776 1.4× 1.2k 2.9× 38 0.1× 46 3.6k

Countries citing papers authored by Hao Xu

Since Specialization
Citations

This map shows the geographic impact of Hao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Xu more than expected).

Fields of papers citing papers by Hao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Xu. The network helps show where Hao Xu may publish in the future.

Co-authorship network of co-authors of Hao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Xu. A scholar is included among the top collaborators of Hao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Xu. Hao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Ming, Hao Xu, Jingjing Liu, et al.. (2025). Neutrophil extracellular traps-triggered hepatocellular senescence exacerbates lipotoxicity in non-alcoholic steatohepatitis. Journal of Advanced Research. 79. 521–534. 4 indexed citations
2.
Zhang, Siqi, Xin Gao, Hui Zeng, et al.. (2024). Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 599–610. 3 indexed citations
3.
Wei, Junjie, Shaojuan Zhang, Chenchen Dong, et al.. (2022). Easily automated radiosynthesis of [18F]P10A-1910 and its clinical translation to quantify phosphodiesterase 10A in human brain. Frontiers in Bioengineering and Biotechnology. 10. 983488–983488. 1 indexed citations
4.
Huang, Yang, Yuan Ding, Zongrui Tong, et al.. (2022). pH-responsive hybrid platelet membrane-coated nanobomb with deep tumor penetration ability and enhanced cancer thermal/chemodynamic therapy. Theranostics. 12(9). 4250–4268. 42 indexed citations
5.
Xu, Hao, Ziyi Cheng, Yan Wei, et al.. (2021). Human Cancer Cell Membrane-Cloaked Fe3O4 Nanocubes for Homologous Targeting Improvement. The Journal of Physical Chemistry B. 125(27). 7417–7426. 22 indexed citations
6.
Ding, Yuan, Zhongquan Sun, Sitong Zhang, et al.. (2021). Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma. BioMed Research International. 2021(1). 7020637–7020637. 15 indexed citations
7.
Xu, Hao, Qianhui Xu, & Lu Yin. (2021). Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysis. Cancer Cell International. 21(1). 344–344. 7 indexed citations
8.
Liu, Chang, et al.. (2020). Two-Dimensional Covalent Organic Frameworks Photocatalysts. Huaxue jinzhan. 32. 274. 2 indexed citations
9.
Zhang, Lingling, Kuan Hu, Tuo Shao, et al.. (2020). Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Acta Pharmaceutica Sinica B. 11(2). 373–393. 116 indexed citations
10.
Yan, Yingcai, Hao Xu, Linshi Zhang, et al.. (2019). <p>RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma</p>. OncoTargets and Therapy. Volume 12. 1691–1703. 27 indexed citations
11.
Xu, Hao, et al.. (2019). Interventional Treatment Strategy for Primary Budd–Chiari Syndrome with Both Inferior Vena Cava and Hepatic Vein Involvement: Patients from Two Centers in China. CardioVascular and Interventional Radiology. 42(9). 1311–1321. 10 indexed citations
12.
Lü, Jian, Hai‐Dong Zhu, Jin‐He Guo, et al.. (2019). Early Warning Models to Estimate the 30-Day Mortality Risk After Stent Placement for Patients with Malignant Biliary Obstruction. CardioVascular and Interventional Radiology. 42(12). 1751–1759. 3 indexed citations
13.
Xu, Hao, et al.. (2016). Risk factors for contralateral recurrence of primary spontaneous pneumothorax after thoracoscopic surgery. 50(2). 138. 1 indexed citations
14.
Huang, Rui, et al.. (2016). Number and function of circulating endothelial progenitor cells in patients with primary Budd-Chiari syndrome. Clinics and Research in Hepatology and Gastroenterology. 41(2). 139–146. 1 indexed citations
15.
Fu, Yu‐Fei, Lulu Lv, Hao Xu, & Ning Wei. (2015). Double Stent Insertion for Combined Malignant Airway and Esophageal Stenoses: Feasibility, Safety, and Long-Term Outcome. Journal of Laparoendoscopic & Advanced Surgical Techniques. 26(1). 11–16. 10 indexed citations
16.
Fu, Yu‐Fei, et al.. (2015). Retrograde puncture assisted hepatic vein recanalization in treating Budd–Chiari syndrome with segmental obstruction of hepatic vein. La radiologia medica. 120(12). 1184–1189. 7 indexed citations
17.
Fu, Yu‐Fei, Ke Zhang, Ning Wei, & Hao Xu. (2014). Significance of an accessory hepatic vein in the interventional treatment of Budd-Chiari syndrome. Zhonghua gan-dan waike zazhi. 20(5). 346–350. 1 indexed citations
18.
Xu, Hao, et al.. (2014). Fibrinolysis status in the Budd–Chiari syndrome in China. Blood Coagulation & Fibrinolysis. 26(7). 721–726. 2 indexed citations
19.
Wang, Yaochun, Shuhong Wang, Hao Xu, et al.. (2013). Notch-RBP-J signaling is required by bone marrow stromal cells for the treatment of acute graft versus host disease. Stem Cell Research. 11(2). 721–735. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinlan Jiang Breakdown of academic impact, for papers by Markus Heine Breakdown of academic impact, for papers by Dawidson Assis Gomes Breakdown of academic impact, for papers by Massoud Vosough Breakdown of academic impact, for papers by Katsunori Sasaki Breakdown of academic impact, for papers by Nan Zhao Breakdown of academic impact, for papers by Noriko Sato Breakdown of academic impact, for papers by Nathalie Luciani
Rankless by CCL
2026